185 related articles for article (PubMed ID: 14669345)
1. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor.
Li CP; Lee FY; Hwang SJ; Lu RH; Lee WP; Chao Y; Wang SS; Chang FY; Whang-Peng J; Lee SD
World J Gastroenterol; 2003 Dec; 9(12):2832-5. PubMed ID: 14669345
[TBL] [Abstract][Full Text] [Related]
2. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis.
Li CP; Lee FY; Hwang SJ; Chang FY; Lin HC; Lu RH; Hou MC; Chu CJ; Chan CC; Luo JC; Lee SD
Am J Gastroenterol; 1999 Feb; 94(2):502-7. PubMed ID: 10022654
[TBL] [Abstract][Full Text] [Related]
3. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function.
Li CP; Lee FY; Hwang SJ; Chang FY; Lin HC; Lu RH; Hou MC; Chu CJ; Chan CC; Luo JC; Lee SD
Scand J Gastroenterol; 1999 May; 34(5):520-3. PubMed ID: 10423070
[TBL] [Abstract][Full Text] [Related]
4. [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type].
Yujuan T; Shaoquan C; Zaizhong Z; Shuming C; Guoliang H; Lie W
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul; 31(4):268-73. PubMed ID: 26665926
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
[TBL] [Abstract][Full Text] [Related]
6. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations.
El-Raggal NM; El-Farrash RA; Saad AA; Attia EAS; Saafan HA; Shaaban IS
Clin Appl Thromb Hemost; 2018 May; 24(4):663-668. PubMed ID: 28595487
[TBL] [Abstract][Full Text] [Related]
8. [Expression of bFGF and VEGF in acute leukemia and its effects on HL-60 cell growth].
Zhang WP; Chun XQ; Zhang YQ; Liang R; Li YH; Gao GX; Zhu HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):91-4. PubMed ID: 15748443
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
[TBL] [Abstract][Full Text] [Related]
10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
Waltham M; Burnand KG; Collins M; Smith A
J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
Komorowski J; Jankewicz J; Stepień H
Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
